Global Marketing of Lifesaving Drugs: an Analogical Model

Rehan Naqvi; Geetha Kumari Das; Zameer  Ahmed; Sambreen Associate

doi:10.59890/27bmwc46

Authors

Rehan Naqvi Riggs Pharmaceutical Author
Geetha Kumari Das OPJS University Rajasthan, India Author
Zameer Ahmed University of Health Sciences, Karachi Author
Sambreen Associate University of Health Sciences, Karachi Author

DOI:

https://doi.org/10.59890/27bmwc46

Keywords:

Global Advertising and Marketing, Lifesaving Drugs, Analogical Version, Pharmaceutical Industry, Accessibility, Affordability, Healthcare Disparities, Strategic Partnerships, Regulatory Model, Ethical Advertising, Digital Health Platform

Abstract

The global advertising and marketing of lifesaving drugs offers a unique set of traumatic conditions and possibilities due to the essential nature of those drug remedies and the various healthcare landscapes at some stage in tremendous international locations. This paper proposes an analogical model that would serve as a guide for pharmaceutical companies to optimize their international marketing techniques for lifesaving drugs. The version attracts successful practices from numerous industries and adapts them to the pharmaceutical context, emphasizing scalability, adaptability, and cultural sensitivity. Key elements embody the reputation quo of strategic partnerships, neighborhood market version, regulatory navigation, and pricing techniques that stabilize profitability with social obligation. Furthermore, the version highlights the significance of leveraging virtual structures for recognition campaigns, allowing healthcare companies and sufferers to get admission to correct statistics. With the aid of adopting this analogical version, pharmaceutical organizations can better navigate worldwide markets, aligning their strategies with every industrial dream and ethical difficulty. The model pursues to create a framework that not only supports the growth of pharmaceutical corporations but additionally addresses international fitness inequalities with the aid of improving the attainment and effect of lifesaving drugs

References

Ashcroft, R.E. (2001). A much less costly approach to life-saving medical processes in underdeveloped nations: Conflicts among moral and industrial desires. Magazine of Medicine and Philosophy, 27(2), 179-195.

Calfee, J.E., & Bate, R. (2004). Prescription drugs and the general HIV epidemic: Can model pictures companion? Journal of Public Relations and Advertising and Marketing and Advertising and Marketing, 23(2), one hundred and forty-152.

Danzon, P.M. (1997). Distortion of drug treatment payments: US and Eu Prosperity assets. Worldwide journal of enterprise Economics, 4(3), 301-321.

Danzon, P.M., & Towse, A. (2003). Differential estimates of prescribed drugs: responsiveness, studies and improvement, and patents. Worldwide Journal of Healthcare Finance and Economics, three, 183-205.

Garrett, L., & Rosenstein, S. (2005). Missed comfort. Harvard International Evaluate, 27(1), sixty-four-70.

Gavetti, G., & Rivkin, J.W. (2005). How Strategists guess: using the power Analogy. Harvard commercial enterprise assessment, eighty-3 (four), 54-Sixty-three.

Gottlieb, M.S. (2001). AIDS – past and the destiny. New England magazine of drugs, 344, 1788-1791.

Kennedy, C.R., Harris, F.H., & Lord, M. (2004). Integrating law affecting most of the people and Public court cases inside the Drug buy application: AIDS preferred. Magazine of Public Policy and Marketing, 23(2), 128-139.

Kim, W.C. and Mauborgne, R. (2004), “Blue Ocean Approach”, Harvard Business Review, October, pp. 76-85 McGrath, R.G. and MacMillan, I.C. (2005), “Marketplace busting: techniques for outstanding commercial enterprise increase”, Harvard Enterprise Evaluation, March, pp. 80-91

Kremer, M. (2002). Prescribed drugs and the growing global. Magazine of economic perspectives, 16(4), 67-ninety.

Letelier, M.F., Flores, F. and Spinosa, C. (2003), growing efficient clients in rising markets”, with the aid of Edward C.inexperienced, California control overview, Vol. 45 No. 4

Nierle, T. (2003), “Humanitarian medication: one person at a time” to be had at: www.doctorswithoutborders.org/ guides/ar/i2003/humanitarian medicine.shtml

Prahalad, C.ok. (2004), “Why promoting to the poor makes for suitable business sense”, Fortune, Vol. 150 No. 10, pp. 70-2.

Prahalad, C C. and Hammond, A. (2002), “Serving the world’s negative, profitably”, Harvard Business Review, Vol. 80 No. 9 pp. 48-9.

Rosen, S., Vincent, J.R., MacLeod, W., Fox, M., & Thea, D.M. (2003). AIDS is your chance. Harvard Business Assessment, 81(2), 80-one-87.

UNAIDS (2004), 2004 record on the worldwide AIDS Epidemic,UNAIDS, Geneva accessible, C. (2002), “What’s an enterprise for?”, Harvard Enterprise Review, Vol. eighty No. 12.